LMR Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,668
| Closed | -$1.91M | – | 1141 |
|
|
2024
Q4 | $1.91M | Hold |
48,668
| – | – | 0.02% | 341 |
|
|
2024
Q3 | $1.92M | Hold |
48,668
| – | – | 0.02% | 271 |
|
|
2024
Q2 | $1.9M | Hold |
48,668
| – | – | 0.02% | 261 |
|
|
2024
Q1 | $2.1M | Buy |
48,668
+47,710
| +4,980% | +$2.05M | 0.02% | 228 |
|
|
2023
Q4 | $44.1K | Sell |
958
-24,042
| -96% | -$1.11M | ﹤0.01% | 479 |
|
|
2023
Q3 | $854K | Buy |
+25,000
| New | +$854K | 0.01% | 333 |
|
|
2023
Q1 | – | Sell |
-50,000
| Closed | -$1.97M | – | 1166 |
|
|
2022
Q4 | $1.97M | Sell |
50,000
-15,698
| -24% | -$619K | 0.03% | 527 |
|
|
2022
Q3 | $2.37M | Sell |
65,698
-34,302
| -34% | -$1.24M | 0.04% | 469 |
|
|
2022
Q2 | $3.04M | Buy |
+100,000
| New | +$3.04M | 0.05% | 395 |
|